Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 20, 2026 03:00 ET | Source: Kuntarahoitus Oyj

Kuntarahoitus laskee liikkeeseen 500 miljoonan Yhdysvaltain dollarin viitelainan osana joukkovelkakirjalainaohjelmaa

Kuntarahoitus OyjPörssitiedote20.1.2026 klo 10.00 Kuntarahoitus laskee liikkeeseen 500 miljoonan Yhdysvaltain dollarin viitelainan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee...
January 20, 2026 03:00 ET | Source: Municipality Finance Plc

Municipality Finance issues USD 500 million benchmark under its MTN programme

Municipality Finance PlcStock exchange release 20 January 2026 at 10:00 am (EET) Municipality Finance issues USD 500 million benchmark under its MTN programme Municipality Finance Plc issues USD...
January 20, 2026 01:00 ET | Source: Wisekey International Holding Ltd.

WISeKey, WISeSat.Space and SEALSQ To Host “Trust and Convergence 2026: The Year of Quantum Security” Discussions During Flagship Davos Gathering

WISeKey, WISeSat.Space and SEALSQ To Host “Trust and Convergence 2026: The Year of Quantum Security” Discussions During Flagship Davos Gathering More information, full event and registration details...
January 19, 2026 01:00 ET | Source: Wisekey International Holding Ltd.

WISeKey and Partners Present the Human-AI-T Manifesto to at Davos 2026 during the WISeKey Event

WISeKey and Partners Present the Human-AI-T Manifesto at Davos 2026 during the WISeKey Event Ensuring Human Control, Trust, and Values in the Age of AGI and Quantum Computing For more information...
January 19, 2026 01:00 ET | Source: Clariant International Ltd

Clariant Board of Directors proposes the election of Regula Wallimann and Albert Manifold to the Board

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Muttenz, 19 January 2026 Clariant, a sustainability-focused specialty chemical company, today announced that the Board of Directors decided to propose to...
January 16, 2026 12:00 ET | Source: Novartis Pharma AG

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease

Designation based on clinical evidence supporting potential of ianalumab in Sjögren’s disease, including phase III trials1Distinction expedites development and review of treatments for serious...
January 15, 2026 03:00 ET | Source: Kuntarahoitus Oyj

Kuntarahoitus laskee liikkeeseen 2 miljardin Ruotsin kruunun joukkovelkakirjalainan osana joukkovelkakirjalainaohjelmaa

Kuntarahoitus OyjPörssitiedote15.1.2026 klo 10.00 Kuntarahoitus laskee liikkeeseen 2 miljardin Ruotsin kruunun joukkovelkakirjalainan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee...
January 15, 2026 03:00 ET | Source: Municipality Finance Plc

Municipality Finance issues SEK 2 billion notes under its MTN programme

Municipality Finance PlcStock exchange release 15 January 2026 at 10:00 am (EET) Municipality Finance issues SEK 2 billion notes under its MTN programme Municipality Finance Plc issues SEK 2...
January 15, 2026 01:00 ET | Source: Ascom Holding AG

Ascom vorläufige Ergebnisse 2025

Ad hoc-Mitteilung gemäss Art. 53 KRBaar (Schweiz), 15. Januar 2026Basierend auf vorläufigen, ungeprüften Zahlen erzielte Ascom im Geschäftsjahr 2025 einen Umsatz von CHF 292,1 Mio., was einem Wachstum...
January 15, 2026 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy

Commercial launch in Switzerland anticipated in H2 2026 Pratteln, Switzerland, January 15, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces that the Swiss Agency for Therapeutic Products...